NCT00427258撤回1 期
An Open-Label, Single-Dose Study of the Mass Balance and Metabolic Disposition of Orally Administered [14C]MOA-728 in Healthy Men
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 撤回
- 主要终点
- Distribution of drug using radioactive study drug.
研究概览
简要总结
Absorption, distribution, metabolism, and excretion (ADME) study with 14C in healthy young men.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Men aged 18 to 50 years inclusive at screening.
- •Body mass index (BMI) in the range of 18.0 to 30.0 kg/m2 and body weight ≥50 kg. BMI is calculated by taking the subject's weight, in kilograms, divided by the square of the subject's height, in meters, at screening: BMI = weight (kg)/[height (m)]2
- •Healthy as determined by the investigator on the basis of screening evaluations.
- •Nonsmoker or smoker of fewer than 10 cigarettes per day as determined by history. Must be able to abstain from smoking during the inpatient stay.
排除标准
- 未提供
结局指标
主要结局
Distribution of drug using radioactive study drug.
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
Study Evaluating Oral Administrations of HKI-272 in Healthy Male SubjectsHealthyNCT00550212Puma Biotechnology, Inc.6
已完成
1 期
Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male SubjectsArthritisNCT02880670Bristol-Myers Squibb9
已完成
1 期
A Human Mass Balance Study to Determine the Total Recovery of Radioactivity in Urine and Faeces Following a Single Oral Dose of 14C Radiolabelled ONO-4053Healthy Adult Male SubjectsNCT01909986Ono Pharmaceutical Co. Ltd8
已完成
1 期
A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy ParticipantsAnti-neutrophil Cytoplasmic Antibody-associated VasculitisNCT06004960Amgen6
已完成
1 期
Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in VolunteersSolid TumoursNCT01931761AstraZeneca6